Development of natural killer cell based trispecific killer engagers (TriKEs) as novel immunotherapy for metastatic breast cancer

Project: Research project

Project Details

Description

Development of natural killer cell based trispecific killer engagers (TriKEs) as novel immunotherapy for metastatic breast cancer
StatusActive
Effective start/end date3/30/203/29/22

Funding

  • METAVIVOR RESEARCH AND SUPPORT, INC.